Representative Cases

• He is renowned for his adept using of complex deal structures, profound insights into PRC legal system & commercial landscape, continuous focus on high-tech industries, exceptional ability to drive transactions forward, and seamless coordination among partners across different practice areas.
• In the field of private equity investment​​, he has represented dozens of institutional investors, including ​​5Y Capital, Long Hill Capital, SPIC(国家电投), SSCI(上海国投), Fortera Capital, Lingang Ventures, Shanghai Angel Capital Guiding Fund, Cenova Ventures, Enlight Growth Partners, Sinovation Ventures, Zhejiang Private Enterprise Joint Investment, Ivy Capital, Kaitai Capital, Panda Capital, Ping An Ventures, ​Yuantai Investment Partners, Newgen capitals, New Access Capital, Atlas Capital, Prime Light Capital, Engage Capital, LC Ventures as well as companies such as ​​YY, ATRenew, WeDoctor, YITU, and SouChe​​ in completing nearly ​​1,000 equity investment transactions​​. He has also advised nearly ​​100 companies​​ in securing equity financing. Among these deals, (i) t​he financing of Xpeng AeroHT​​ led by 5Y Capital was recognized as ​​"Deal of the Year 2021"​​ by China Business Law Journal; (ii) ​​the financing of Abogen Biosciences​​ led by 5Y Capital was recognized as ​​"Deal of the Year 2022"​​ by China Business Law Journal; and (iii) the pre-IPO financing of Weilong Delicious Global Holdings Ltd. (HK 09985) remains ​​the largest equity financing transaction in China’s food industry​​ to date.
• In the the field of M&A, his notable transactions include: (i) ​​ATRenew’s acquisition of JD’s Paipai business​​, recognized as ​​"Deal of the Year 2019"​​ by China Business Law Journal; (ii) ​​G7’s merger with Shenzhen E6 Technology​​, awarded the ​​"LegalOne Merits (Remarkable)" rating​​ by LegalOne; and (iii) ​​YSB Inc’s acquisition o Hunan Yikuai Pharmaceutical Technology, the ​​PRC’s largest deal in pharmaceutical distribution sector of 2024​​. Additionally, he​​ has successfully advised clients in their respective transactions​​ with Alibaba, Pinduoduo, Baidu, and MNCs involving ​sales of ​asset/business, MBOs and equity trade sales.
• In the field of general corporate services, he​​ has provided legal counsel to over ​​100 companies​​ on matters of ​​equity restructuring, investment/acquisitions, ESOP/Employee Incentive Plan, cybersecurity/data protection, technology licensing as well as dispute settlement​​, which benefited them a lot in their growth. Many of these companies have ​​successfully been listed​​, while others have emerged as ​​renowned unicorns, which​ ​include ​​China Mobile, Kuaishou, Alipay, SMEE, Far East Horizon (Fehorizon), ATRenew, Weilong Delicious Global, ​​YSB Inc, J&T Express, Allianz Partners, Yunnan Baiyao, 3D Medicines, Medical System, Labway Medical, WeDoctor, Souche, Xiaozhu, YITU, HotMax, Shukun Technology, RobotPlusPlus, Huanle Entertainment, IC Bench, OUTPUT and ​​One Step Garden.
•